Cite
HARVARD Citation
Arulogun, S. et al. (2023). Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing. American journal of hematology. 98 (5), pp. 750-759. [Online].